ACRIVASTINE
UNII A20F9XAI7W

Substance Identification & Data

This profile provides standardized clinical and technical data for Acrivastine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) A20F9XAI7W.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 87848-99-5 and the RxNorm Concept ID (RxCUI) 19959. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

A20F9XAI7W

CAS Registry Number

87848-99-5

RxNorm Concept ID

19959

Detailed Substance Profile

Preferred Name

ACRIVASTINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C22H24N2O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

PWACSDKDOHSSQD-IUTFFREVSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C47383

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

5284514

Unique identification number in the NCBI database of chemical substances.

INN ID

5548

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

X-7

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(=C/CN1CCCC1)(\c2nc(\C=C\C(=O)O)ccc2)/c3ccc(cc3)C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Acrivastine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.